The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer. Roels J, Ghaedi H, Kancherla J, Yang Y, et al. Cancer Res 2026;86:2592-2605.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roels J, Ghaedi H, Kancherla J, Yang Y, et al. The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer. Cancer Res 2026;86:2592-2605.
PMID: 41784658